Literature DB >> 28648975

Effect of extract of Pueraria tuberosa on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in kidney of diabetic rats.

Rashmi Shukla1, Nidhi Pandey1, Somanshu Banerjee2, Yamini B Tripathi3.   

Abstract

BACKGROUNDS: Kidney hypoxia represents a unifying mechanism in the pathogenesis of diabetic nephropathy. Hypoxia-induced factor (HIF)-1α mediates the metabolic responses of renal hypoxia by modulating the expression of VEGF. In the present study, we investigated the effect of Pueraria tuberosa extract (PTY-2r) on the expression of HIF-1α, VEGF and nephrin in streptozotocin (STZ) induced diabetic nephropathy (DN).
METHODS: The model of diabetic nephropathy (DN) was produced by intraperitoneal injection of 55mg/kg of STZ and maintained for 60days. These DN-rats were randomly divided into three groups, i.e., DN, DN+PTY-2r (100mg/100g), and DN+PTY-2r (50mg/100g). A normal control (NC) group was administrated with drug vehicle. Expression of HIF-1α, VEGF and nephrin were evaluated in the renal tissue.
RESULTS: Blood glucose, urine protein, serum creatinine, and urea, level were significantly raised along with decreased creatinine clearance in DN rats. Immunofluorescence and Western blot analysis showed significantly increased expression of HIF-1α & VEGF and decreased expression of nephrin in DN control rats. The PTY-2r treatment significantly reversed these changes in a dose-dependent manner. Correlation analysis showed that the expression of VEGF was positively correlated with that of HIF-1α and negatively correlated with nephrin.
CONCLUSIONS: The PTY-2r can improve the chronic hyperglycemic condition induced kidney damage, and may delay the development of diabetic nephropathy by inhibiting the expression of HIF-1α and VEGF, thereby restoring the expression of nephrin.
Copyright © 2017. Published by Elsevier Masson SAS.

Entities:  

Keywords:  Diabetic nephropathy; HIF-1α; Nephrin; Phytomedicine; Pueraria tuberosa; VEGF

Mesh:

Substances:

Year:  2017        PMID: 28648975     DOI: 10.1016/j.biopha.2017.06.045

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.

Authors:  Massimo Dal Monte; Maurizio Cammalleri; Valeria Pecci; Monica Carmosino; Giuseppe Procino; Alessandro Pini; Mario De Rosa; Vincenzo Pavone; Maria Svelto; Paola Bagnoli
Journal:  J Cell Mol Med       Date:  2018-11-13       Impact factor: 5.310

2.  Evaluation of Renal Pathophysiological Processes Induced by an Iodinated Contrast Agent in a Diabetic Rabbit Model Using Intravoxel Incoherent Motion and Blood Oxygenation Level-Dependent Magnetic Resonance Imaging.

Authors:  Yongfang Wang; Xin Zhang; Bin Wang; Yang Xie; Yi Wang; Xuan Jiang; Rongjia Wang; Ke Ren
Journal:  Korean J Radiol       Date:  2019-05       Impact factor: 3.500

Review 3.  Promising Therapeutic Candidate for Myocardial Ischemia/Reperfusion Injury: What Are the Possible Mechanisms and Roles of Phytochemicals?

Authors:  Cong Chen; Lin-Tong Yu; Bai-Ru Cheng; Jiang-Lin Xu; Yun Cai; Jia-Lin Jin; Ru-Li Feng; Long Xie; Xin-Yan Qu; Dong Li; Jing Liu; Yan Li; Xiao-Yun Cui; Jin-Jin Lu; Kun Zhou; Qian Lin; Jie Wan
Journal:  Front Cardiovasc Med       Date:  2022-02-17

4.  Antioxidant and Antiapoptotic effect of aqueous extract of Pueraria tuberosa (Roxb. Ex Willd.) DC. On streptozotocin-induced diabetic nephropathy in rats.

Authors:  Rashmi Shukla; Somanshu Banerjee; Yamini B Tripathi
Journal:  BMC Complement Altern Med       Date:  2018-05-11       Impact factor: 3.659

5.  Active phytochemicals of Pueraria tuberosa for DPP-IV inhibition: in silico and experimental approach.

Authors:  Shivani Srivastava; Priya Shree; Yamini Bhusan Tripathi
Journal:  J Diabetes Metab Disord       Date:  2017-11-21

6.  Increased expression of hypoxia inducible factor-1 alpha and vascular endothelial growth factor is associated with diabetic gastroparesis.

Authors:  Xueping Wu; Zhifang Yang; Zhihong Li; Ling Yang; Xinyan Wang; Congrong Wang; Jun Gu
Journal:  BMC Gastroenterol       Date:  2020-07-10       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.